A new research perspective was published in Oncotarget’s Volume 14 on August 7, 2023, entitled, “CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies.”
Tech companies pitch AI platforms for healthcare, outline plans for responsible rollout
Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. LAS VEGAS — Executives from America’s largest